- Home
- PSTV vs CYN Comparison
PSTV vs CYN Comparison
Compare PSTV & CYN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PSTV
- CYN
- Stock Information
- Founded
- PSTV 1996
- CYN 2013
- Country
- PSTV United States
- CYN United States
- Employees
- PSTV N/A
- CYN N/A
- Industry
- PSTV Medical/Dental Instruments
- CYN EDP Services
- Sector
- PSTV Health Care
- CYN Technology
- Exchange
- PSTV Nasdaq
- CYN Nasdaq
- Market Cap
- PSTV 12.2M
- CYN N/A
- IPO Year
- PSTV N/A
- CYN 2021
- Fundamental
- Price
- PSTV $0.62
- CYN $4.36
- Analyst Decision
- PSTV Strong Buy
- CYN
- Analyst Count
- PSTV 3
- CYN 0
- Target Price
- PSTV $12.75
- CYN N/A
- AVG Volume (30 Days)
- PSTV 3.6M
- CYN 47.5K
- Earning Date
- PSTV 05-19-2025
- CYN 05-07-2025
- Dividend Yield
- PSTV N/A
- CYN N/A
- EPS Growth
- PSTV N/A
- CYN N/A
- EPS
- PSTV N/A
- CYN N/A
- Revenue
- PSTV $5,824,000.00
- CYN $409,777.00
- Revenue This Year
- PSTV $13.26
- CYN $1,162.03
- Revenue Next Year
- PSTV $8.84
- CYN $427.83
- P/E Ratio
- PSTV N/A
- CYN N/A
- Revenue Growth
- PSTV 18.54
- CYN N/A
- 52 Week Low
- PSTV $0.24
- CYN $3.62
- 52 Week High
- PSTV $2.67
- CYN $2,700.00
- Technical
- Relative Strength Index (RSI)
- PSTV 43.68
- CYN 35.22
- Support Level
- PSTV $0.49
- CYN $5.05
- Resistance Level
- PSTV $0.90
- CYN $5.49
- Average True Range (ATR)
- PSTV 0.13
- CYN 0.41
- MACD
- PSTV -0.01
- CYN 0.46
- Stochastic Oscillator
- PSTV 17.81
- CYN 32.39
About PSTV PLUS THERAPEUTICS Inc.
Plus Therapeutics Inc is a clinical-stage pharmaceutical company that focuses on discovering, developing, and delivering complex treatments for patients with cancer and rare diseases. The company is working on a range of potential products, with its main programs targeting recurrent glioblastoma (GBM) and leptomeningeal metastases (LM). One of its key candidates, rhenium (186Re) obisbemeda, is specifically designed to treat central nervous system (CNS) cancers such as GBM, LM, and pediatric brain cancers (PBC).